Back to search

Article

CAR Macrophages for SARS-CoV-2 Immunotherapy

2020-07-27

Abstract excerpt

Targeted therapeutics for the treatment of coronavirus disease 2019 (COVID-19), especially severe cases, are currently lacking. As macrophages have unique effector functions as a first-line defense against invading pathogens, we genetically armed human macrophages with chimeric antigen receptors (CARs) to reprogram their phagocytic activity against SARS-CoV-2. After investigation of CAR constructs with different i...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
801e9d43-b538-5dc0-9180-d547c30c1106
DOI
10.1101/2020.07.26.222208
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
CAR Macrophages for SARS-CoV-2 ImmunotherapyDOI 10.1101/2020.07.26.222208
Select a neighboring publication to make it the new centre.